Before she began her first professorship at the University of Manchester in England, Dr. Maria Castro had focused most of her work on neurodegenerative disorders, such as Parkinson’s disease. But after meeting different colleagues and exploring other focus areas, brain cancer became a new field of interest. She was quickly immersed in the world of cancer progression and novel therapeutics. “At the time, no one…